BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3306860)

  • 1. Biological aspects of renal cell carcinoma.
    Vugrin D
    Semin Nephrol; 1987 Jun; 7(2):117-22. PubMed ID: 3306860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heterogeneity of human renal cell carcinoma. III. 1 alpha,25-dihydroxyvitamin D3 receptor and inhibition on the growth of renal carcinoma cell lines].
    Nagakura K
    Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):92-7. PubMed ID: 3014194
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of renal cell carcinoma of horseshoe kidney that produced AFP and caused hypercalcemia].
    Okada H; Kawabata G; Kamidono S; Ishigami J; Nakatsuka E
    Hinyokika Kiyo; 1984 Oct; 30(10):1453-8. PubMed ID: 6084418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Fas/APO-1 in renal cell carcinoma GRC-1 cell line during cell cycles.
    Li H; Yu L; Guo Y; Liang Y; Wang D
    Chin Med J (Engl); 1999 Nov; 112(11):1008-12. PubMed ID: 11721461
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal cell carcinoma with rhabdoid features. Divergent differentiation of conventional (clear cell) carcinoma.
    Klimis T; Karvounis H
    J BUON; 2008; 13(3):433-6. PubMed ID: 18979563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI MS reveals that cells near a tumor aren't so normal.
    Cottingham K
    J Proteome Res; 2010 May; 9(5):2049. PubMed ID: 20334358
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
    Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
    Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcomatoid renal cell carcinoma with osteosarcomatous differentiation--a case report.
    Handoo A; Pai RR; Rao VS; Sanjeeva VB
    Indian J Pathol Microbiol; 2004 Oct; 47(4):528-9. PubMed ID: 16295385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
    Rouvière O; Bouvier R; Négrier S; Badet L; Lyonnet D
    Nat Clin Pract Oncol; 2006 Apr; 3(4):200-13. PubMed ID: 16596144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parvalbumin is constantly expressed in chromophobe renal carcinoma.
    Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F
    Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma.
    Yamasaki M; Nomura T; Mimata H; Nomura Y
    J Urol; 2004 Aug; 172(2):475-6. PubMed ID: 15247706
    [No Abstract]   [Full Text] [Related]  

  • 12. Asynchronous collecting duct carcinoma of the kidney and pulmonary adenocarcinoma. A case report.
    Okoń K; Demczuk S; Dobrowolska B; Kaznowska E; Dobrowolski Z; Stachura J
    Pol J Pathol; 2002; 53(4):229-34. PubMed ID: 12597341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of cell adhesion in renal epithelium without cadherin loss.
    O'Donnell M; Fleming S
    J Pathol; 1995 Jan; 175(1):45-50. PubMed ID: 7891226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic markers in renal cell carcinomas.
    McCue PA; Gorstein F
    Hum Pathol; 2001 Oct; 32(10):1027-8. PubMed ID: 11679934
    [No Abstract]   [Full Text] [Related]  

  • 15. Heavily pigmented renal cell carcinoma: a case report, with review of the literature and differential diagnosis.
    Rossi G; Cadioli A; Costantini M; Grazia Del Buono M; Oleari G
    Int J Surg Pathol; 2009 Apr; 17(2):167-9. PubMed ID: 18701515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse expression of MUC 1 in metastases of renal clear cell carcinoma as a possible therapeutic target for renal cancer.
    Leroy X; Aubert S; Ballereau C; Birembaut P; Porchet N; Gosselin B; Copin MC
    Histopathology; 2005 Oct; 47(4):435-6. PubMed ID: 16178902
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal cell carcinoma in a transplanted kidney.
    Joyce MR; O'Shea LA; Deepak AF; Falke L; Ryan T; O'Dowd G; Sidiquii A
    Ir Med J; 2000; 93(5):155. PubMed ID: 11072929
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecularly targeted therapies for renal cell cancer: TRAIL research advances.
    Buttyan R; Mian BM
    J Urol; 2007 May; 177(5):1606. PubMed ID: 17437767
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormone receptors in human renal cell carcinomas?].
    Krech RH; Grote M; Vollmer G; Gerdes J; Löhrs U
    Verh Dtsch Ges Pathol; 1988; 72():241-4. PubMed ID: 3218339
    [No Abstract]   [Full Text] [Related]  

  • 20. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
    Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
    Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.